Amnestic

amnestic patients

amnestic medications

Most often, persons who first present with language, comportmental, and visuospatial difficulties are under the age of 65, in contrast to the older age at onset of individuals with amnestic dementia.

Thus, while not exhibiting the large dose separation predicted from preclinical tests, alpidem did not impair memory at therapeutic doses (and was reported to antagonize the amnestic actions of a BZ), nor did chronic treatment produce a withdrawal reaction after abrupt termination.

1,4-BZ are also excellent sedative-hypnotics, muscle relaxants, amnestics (useful as preoperative medications), and anticonvulsants. The demonstration of receptor heterogeneity led to the hypothesis that these pharmacological actions are separable; the in vivo profile of CL 218,872 provided the proof of principle that such a separation could be achieved.